Connect with us

Technologies

What Does Measles Look Like in Adults? We Ask Doctors Who Should Get Vaccinated Again

As measles cases continue to increase in the United States, this is what you should know about symptoms and your MMR vaccine status.

As of April 18, the Centers for Disease Control and Prevention reports that there have been 10 outbreaks and 800 confirmed measles cases in 25 US states in 2025. Of these cases, 96% of those affected are unvaccinated or have an unknown vaccine status. There have been two confirmed deaths caused by measles and one death that is still under investigation. 

The Texas Department of State Health Services reports that, primarily in West Texas, 624 cases have been confirmed. Both deaths also occurred in two school-aged children who lived in Texas’s South Plains outbreak area. Both children were not vaccinated.

According to the CDC, two doses of the MMR (measles, mumps and rubella) vaccine are 97% effective at preventing measles, while one dose is 93% effective. It is uncommon for someone who is fully vaccinated to develop measles. To learn more about measles symptoms and whether you need to get vaccinated again, we spoke with doctors for their expert insights.

What does measles look like in adults and children? 

Measles is one of the world’s most contagious viruses with a number of symptoms to look out for — most notably a rash and fever, according to the CDC. The virus is spread through the air, and once infected, measles attacks your respiratory tract. 

The Cleveland Clinic notes that there is no cure for measles, and measles just has to «run its course.» However, the best protection from it is a measles vaccine, which is typically given to babies in the form of the MMR (measles, mumps and rubella) vaccine. 

Measles typically manifests at first as a «very specific rash that starts from the face and spreads down your body,» says Dr. Yoshua Quinones, board-certified internist with Medical Offices of Manhattan. Other common side symptoms to watch out for include «high fever, cough, runny nose and watery or red eyes.»

Quinones adds, «Occasionally, you may see small white spots inside your mouth. These are named Koplik spots.»

While measles can and will make anyone sick, the CDC reports that it is especially dangerous for children younger than 5. This is because children have undeveloped immune systems and are at a higher risk of illnesses, making them vulnerable — especially if they haven’t been vaccinated.

How does the measles vaccine work?

The measles vaccine protects people from getting measles. It’s known as the MMR, because it’s combined with the vaccines for mumps (a contagious viral infection that affects the salivary glands) and rubella (another contagious viral infection that typically starts with a red facial rash). You may also see the MMRV, which includes a vaccine for varicella or chickenpox. 

«The vaccine is a live virus that is introducing a very weak form of measles so your body can practice fighting it off,» says Quinones. «This will prepare your immune system to fight against measles if you’re exposed.»

One dose is typically given during infancy, with a second dose to follow a few years later. The vaccination is especially important for children because their immune systems are weaker. This is why both doses are recommended before they are in school, where they will be exposed to more children (and more germs). 

Who should get the measles vaccine? 

Measles vaccines are typically given to all children. The first vaccine is usually given between 12 and 15 months of age and the second one is given between 4 and 6 years of age before children go to school, according to the CDC. The ages can vary, though, as long as the doses are properly spaced out. 

Vaccines can also be given to adults who haven’t previously been vaccinated or are not immune, although they typically only get one dose. Dr. Omar Al-Heeti, an assistant professor of medicine at Southern Illinois University who practices internal medicine with a specialty in infectious diseases, and one of CNET’s medical reviewers, adds that adults born during or after 1957 should have at least one dose of the MMR vaccine or presumptive evidence of immunity.

According to Al-Heeti, presumptive evidence of immunity is defined as one of the following:

  • Written documentation of vaccination with two doses of live measles or MMR vaccine administered at least 28 days apart
  • Laboratory evidence of immunity (positive serum IgG)
  • Laboratory confirmation of disease
  • Birth before 1957 (According to the CDC, although birth before 1957 is considered presumptive evidence of immunity, for unvaccinated health-care personnel (HCP) born before 1957 who lack laboratory evidence of measles immunity or laboratory confirmation of disease, health-care facilities should consider vaccinating personnel with two doses of MMR vaccine at the appropriate interval.)

The CDC recommends that adults who work in the health-care field, attend college or university, or travel internationally get two doses separated by at least 28 days, as they are deemed to be at higher risk for acquiring the infection.

Should you get a measles booster if you were already vaccinated? 

Despite the ongoing measles outbreak, there is likely no need to get an additional measles vaccine — unless you aren’t fully vaccinated already or have proven immunity (previous infection/exposure).

«If someone is fully vaccinated against measles (two doses) and has not had a major immunocompromising condition occur (e.g., organ transplant), their immunity should be sufficient with no need for further dosages,» says Amesh A. Adalja, an infectious disease specialist and a senior scholar at Johns Hopkins Center for Health Security.

The first measles vaccine dose is usually given to infants and toddlers, with the second dose given during the childhood years. If the second dose was never given, someone could be at higher risk for measles and would, in fact, benefit from another measles vaccine now. 

A recent report noted that some people originally vaccinated in the 1970s and 1980s may need a new vaccine because the original wore off. This could be because they were only given one dose and the vaccine has evolved since then, and it was potentially not caught in some people’s medical records. 

«If you already have your full series, you don’t need an additional dose; however, I highly recommend checking your titers if you have any doubts,» Quinones says. «An extra shot will never add extra protection because you’re very well protected.» According to Mount Sinai, an antibody titer test measures the level of antibodies in a blood sample to see which vaccines you may need.

Ask your primary care doctor to check your vaccination status to see if your MMR vaccination is up to date and to see if you may need a booster. If it’s current and you are not immunocompromised, you likely do not need an extra shot. The CDC also notes that adults who have received a single dose and have «presumptive evidence of immunity» — documentation of vaccination or immunity — don’t need to get another one.

Who shouldn’t get the measles vaccine? 

While the measles vaccine is generally considered safe, some groups of people are advised to avoid it. Quinones recommends that pregnant people not get the vaccine. It is also advised to wait at least a month after giving birth before getting a vaccine.

The CDC also recommends that people who had an allergic reaction to the first MMR vaccine hold off on getting the second dose. In addition, people with any «severe, life-threatening» allergies should consult their doctor before getting vaccinated because it may not be safe. 

Those with weakened immune systems should also consult their doctor about getting the vaccine, especially if it is because of disease or medical treatment. If immunodeficiencies run in the family, this could also cause an issue with the shots. 

The vaccines can also potentially react with recent blood transfusions so it’s not recommended to get the MMR or MMRV within at least three months of receiving blood from someone. You should also not get the vaccine if you currently have tuberculosis or bruise or bleed easily, according to the CDC. 

The MMR doses need to be spaced out by at least 28 days, and you should also not get one of these doses if you’ve had another vaccine within 28 days as well. It’s also important to let your health-care provider know if you’ve been sick recently — with any sort of illness — so they can advise if it’s still safe to vaccinate. If you’re a parent bringing in a child for vaccination, also advise the doctor if the baby has been sick or shown any previous symptoms of concern.

Or if you were born before 1957, you may already have immunity. 

Is the measles vaccine safe? 

According to medical experts and the CDC, the measles vaccine is safe and effective. Some slight side effects may occur after getting the shot, but they are generally minor and go away quickly.

«The measles vaccine may cause fever, chills and muscle aches/pains in the days after injection,» Adalja said.

Quinones also points out that it’s possible to feel sore at the injection site following the shot. 

Beyond this, the CDC reports that it’s possible to see some swelling in the cheeks or neck and in rare cases, a bleeding disorder that will eventually resolve itself. In more severe cases, it’s possible to have an allergic reaction to the vaccine, which would require calling 911 right away, especially if there’s trouble breathing, intense swelling or dizziness. 

The CDC also reports a small link between the MMR vaccine and febrile seizures, but it is rare and not linked to long-term effects. However, the organization recommends that parents vaccinate their children early to lessen the chances of this occurring. 

The CDC also calls out the notion that vaccines were once linked to autism and shuts down any possibility that the two are related to each other, citing experts and research. The CDC states, «There is no link between autism and vaccines that contain thimerosal as a preservative.»

Does health insurance cover the measles vaccine? 

Typically, all Health Insurance Marketplace plans and private insurance plans offer the MMR vaccine (as well as other common vaccines) without charging a copayment or coinsurance, as long as you’re with an in-network provider, according to the CDC. Medicare likely also covers the vaccine, whether on Part B or Part D, and so does Medicaid, but it’s always best to double-check with your medical facility and with Medicare or Medicaid to be certain. 

Military benefits can also vary depending on coverage, but the MMR vaccine will most likely be covered, as the CDC recommends it be covered across the board.

The bottom line 

Despite the outbreak that is currently happening in the United States, people do not need to get another measles vaccine if they’ve already sufficiently been vaccinated. However, doctors suggest checking with your health-care provider if you have any concerns about the efficacy of the vaccinations you received and to find out if a booster shot could be necessary, especially if there is an outbreak in your community. If so, experts make it clear that the measles vaccine is safe and will protect you from the virus.

Technologies

Google races to put Gemini at the center of Android before Apple’s AI reboot

Google is using its latest Android rollout to position Gemini as the AI layer across phones, Chrome, laptops and cars.

Google is using its latest Android rollout to make Gemini less of a chatbot and more of an operating layer across the phone, browser, car and laptop, just weeks before Apple is expected to show its own Gemini-powered Apple Intelligence reboot at WWDC.
Ahead of its Google I/O developer conference next week, the company previewed a number of Android updates, including AI-powered app automation, a smarter version of Chrome on Android, new tools for creators, a redesigned Android Auto experience, and a sweeping set of new security features.
Alphabet is counting on Gemini to help Google compete directly with OpenAI and Anthropic in the market for artificial intelligence models and services, while also serving as the AI backbone across its expansive portfolio of products, including Android. Meanwhile, Gemini is powering part of Apple’s new AI strategy, giving Google a role in the iPhone maker’s reset even as it races to prove its own version of personal AI on the phone is further along.
Sameer Samat, who oversees Google’s Android ecosystem, told CNBC that Google is rebuilding parts of Android around Gemini Intelligence to help users complete everyday tasks more easily.
“We’re transitioning from an operating system to an intelligence system,” he said.
As part of Tuesday’s announcements. Google said Gemini Intelligence will be able to move across apps, understand what’s on the screen and complete tasks that would normally require a user to jump between multiple services. That means Android is moving beyond the traditional assistant model, where users ask a question and get an answer, and acting more like an agent.
For instance, Google says Gemini can pull relevant information from Gmail, build shopping carts and book reservations. Samat gave the example of asking Gemini to look at the guest list for a barbecue, build a menu, add ingredients to an Instacart list and return for approval before checkout.
A big concern surrounding agentic AI involves software taking action on a user’s behalf without permissions. Samat said Gemini will come back to the user before completing a transaction, adding, “the human is always in the loop.”
Four months after announcing its Gemini deal with Google, Apple is under pressure to show a more capable version of Apple Intelligence, which has been a relative laggard on the market. Apple has long framed privacy, hardware integration and control of the user experience as its advantages.
Google’s Android push is designed to show it can bring AI deeper into the device experience while still giving users control over what Gemini can see, where it can act and when it needs confirmation.
The app automation features will roll out in waves, starting with the latest Samsung Galaxy and Google Pixel phones this summer, before expanding across more Android devices, including watches, cars, glasses and laptops later this year.
The company is also redesigning Android Auto around Gemini, turning the car into another major surface for its assistant. Android Auto is in more than 250 million cars, and Google says the new release includes its biggest maps update in a decade and Gemini-powered help with tasks like ordering dinner while driving.
Alphabet’s AI strategy has been embraced by Wall Street, which has pushed the company’s stock price up more than 140% in the past year, compared to Apple’s roughly 40% gain. Investors now want to see how Gemini can become more central to the products people use every day.
WATCH: Alphabet briefly tops Nvidia after report of $200 billion Anthropic cloud deal

Continue Reading

Technologies

Waymo recalls 3,800 robotaxis after glitch allowed some vehicles to ‘drive into standing water’

Waymo issued a voluntary recall of about 3,800 of its robotaxis to fix software issues that could allow them to drive into flooded roadways.

Waymo is recalling about 3,800 robotaxis in the U.S. to fix software issues that could allow them to “drive onto a flooded roadway,” according to a letter on the National Highway Traffic Safety Administration’s website.
The voluntary recall is for Waymo vehicles that use the company’s fifth and sixth generation automated driving systems (or ADS), the U.S. auto safety regulator said in the letter posted Tuesday.
Waymo autonomous vehicles in Austin, Texas, were seen on camera driving onto a flooded street and stalling, requiring other drivers to navigate around them. It’s the latest example of a safety-related issue for the Alphabet-owned AV unit that’s rapidly bolstering its fleet of vehicles and entering new U.S. markets.
Waymo has drawn criticism for its vehicles failing to yield to school buses in Austin, and for the performance of its vehicles during widespread power outages in San Francisco in December, when robotaxis halted in traffic, causing gridlock.
The company said in a statement on Tuesday that it’s “identified an area of improvement regarding untraversable flooded lanes specific to higher-speed roadways,” and opted to file a “voluntary software recall” with the NHTSA.
“Waymo provides over half a million trips every week in some of the most challenging driving environments across the U.S., and safety is our primary priority,” the company said.
Waymo added that it’s working on “additional software safeguards” and has put “mitigations” in place, limiting where its robotaxis operate during extreme weather, so that they avoid “areas where flash flooding might occur” in periods of intense rain.
WATCH: Waymo launches new autonomous system in Chinese-made vehicle

Continue Reading

Technologies

Qualcomm tumbles 13% as semiconductor stocks retreat from historic AI-fueled surge

Semiconductor equities reversed sharply after a broad AI-driven advance, with Qualcomm suffering its worst day since 2020 amid inflation concerns and rising oil prices.

Semiconductor stocks fell sharply on Tuesday, reversing course after an extensive rally that had expanded the artificial intelligence investment theme well past Nvidia and driven the industry to unprecedented levels.

Qualcomm plunged 13% and was on track for its steepest single-day decline since 2020. Intel shed 8%, while On Semiconductor and Skyworks Solutions each lost more than 6%. The iShares Semiconductor ETF, which benchmarks the overall sector, fell 5%.

The sell-off came after a key gauge of consumer prices came in above forecasts, and as conflict in Iran pushed crude oil higher—prompting investors to shift away from riskier assets.

The preceding advance had widened the AI opportunity set beyond longtime industry leader Nvidia, which for much of the past several years had largely carried the market to new peaks on its own.

Explosive appetite for central processing units, along with the graphics processing units that power large language models, has sent chipmakers to all-time highs.

Market participants are wagering that the shift from AI model training to autonomous agents will lift demand for additional AI hardware. Among the beneficiaries are memory chip producers, which are raising prices as supply remains tight.

Micron Technology slid 6%, and Sandisk cratered 8%. Sandisk’s stock has surged more than six times over since January.

Continue Reading

Trending

Copyright © Verum World Media